000 01142 a2200325 4500
005 20250516210437.0
264 0 _c20141105
008 201411s 0 0 eng d
022 _a1759-4820
024 7 _a10.1038/nrurol.2014.89
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPosadas, Edwin M
245 0 0 _aKidney cancer: progress and controversies in neoadjuvant therapy.
_h[electronic resource]
260 _bNature reviews. Urology
_cMay 2014
300 _a254-5 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAxitinib
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aIndazoles
_xtherapeutic use
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aNephrectomy
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
700 1 _aFiglin, Robert A
773 0 _tNature reviews. Urology
_gvol. 11
_gno. 5
_gp. 254-5
856 4 0 _uhttps://doi.org/10.1038/nrurol.2014.89
_zAvailable from publisher's website
999 _c23756095
_d23756095